RenovoRx, Inc. (NASDAQ:RNXT) Q1 2025 Earnings Call Transcript May 15, 2025
RenovoRx, Inc. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08.
Valter Pinto – IR:
Ramtin Agah – Founder and Chief Medical Officer:
Shaun Bagai – CEO:
Ronald Kocak – VP Controller and Principal Accounting Officer:
Operator: Good afternoon, everyone, and welcome to the RenovoRx Q1 2025 Financial and Operational Highlights Conference Call. All participants will be in a...
